Start Date
May 31, 1998
Primary Completion Date
August 31, 2002
Study Completion Date
August 31, 2002
recombinant interferon alfa
sargramostim
autologous bone marrow transplantation
Johns Hopkins Oncology Center, Baltimore
National Cancer Institute (NCI)
NIH
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER